Although all valuations are speculative in nature,I believe Col’s is far more plausible than ValueAdd’s. $2/share is way under value in any way the pie is cut.
What if CF33 as a monotherapy outperforms the combination treatments? What if the OV completely disrupts existing treatments altogether? What if it is used as a vaccine? How long can the OV remain viable in the body? Could ppl require an annual / regular vaccine? How will potential combo treatments be split? 50/50, 80/20? The possibilities are vast. If CF33 reaches the heights we are all hoping, every government across the globe will want a piece of it. It will change humanity. Productivity, healthcare costs, quality of life, quality of relationships, no side effects.. the implications are mind-boggling.
In my eyes this company could well be a 100-bagger. I will not be selling at $2/share
IMU Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)